GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AstraZeneca PLC (OTCPK:AZNCF) » Definitions » Total Debt per Share

AZNCF (AstraZeneca) Total Debt per Share : $19.43 (As of Dec. 2024)


View and export this data going back to 2009. Start your Free Trial

What is AstraZeneca Total Debt per Share?

$19.43 (As of Dec. 2024)

Total Debt per Share is calculated as total debt divided by Shares Outstanding (EOP). Total debt is calculated as Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. AstraZeneca's Total Debt Per Share for the quarter that ended in Dec. 2024 was $19.43.

AstraZeneca Total Debt per Share Historical Data

The historical data trend for AstraZeneca's Total Debt per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AstraZeneca Total Debt per Share Chart

AstraZeneca Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Debt per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15.53 19.81 18.80 18.33 19.43

AstraZeneca Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Total Debt per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.33 22.29 21.63 20.36 19.43

AstraZeneca Total Debt per Share Calculation

AstraZeneca's Total Debt Per Share for the fiscal year that ended in Dec. 2024 is calculated as:

Total Debt Per Share=(Long-Term Debt & Capital Lease Obligation+Short-Term Debt & Capital Lease Obligation)/Shares Outstanding (EOP)
=(27,619+2,495)/1,550
=19.43

AstraZeneca's Total Debt Per Share for the quarter that ended in Dec. 2024 is calculated as:

Total Debt Per Share=(Long-Term Debt & Capital Lease Obligation+Short-Term Debt & Capital Lease Obligation)/Shares Outstanding (EOP)
=(27,619+2,495)/1,550
=19.43

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AstraZeneca Total Debt per Share Related Terms

Thank you for viewing the detailed overview of AstraZeneca's Total Debt per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

AstraZeneca Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AstraZeneca PLC (OTCPK:AZNCF) » Definitions » Total Debt per Share
Comparable Companies
LSE:GSK LLY JNJ ABBV OCSE:NOVO B XSWX:ROG MRK XSWX:NOVN AMGN PFE GILD XPAR:SAN BMY TSE:4519 TSE:4568 SHSE:600276 TSE:4578 XTER:BAYN BIIB TSE:4503
Traded in Other Exchanges
AZN:USA AZN:Sweden AZNN:Mexico AZNl:UK AZN:UK ZEGA:Germany ZEG:Germany ZEG:Germany ZEG:Germany ZEGA:Germany ZEG:Germany A1ZN34:Brazil AZNA:Austria AZN:Argentina
Address
1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, GBR, CB2 0AA
Website
https://www.astrazeneca.com
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.